Robert J. Weiland Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Robert J. Weiland.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Robert J. Weiland. Robert J. Weiland is a Director in CymaBay Therapeutics, Inc. ($CBAY) and a Chief Commercial Officer in Pacira Pharmaceuticals, Inc. ($PCRX).

Over the past year Robert J. Weiland has been an insider in 2 companies. The total value of shares held by Robert J. Weiland in these companies amounts to $212,424.

Robert J. Weiland Director
CymaBay Therapeutics, Inc.
Chief Commercial Officer
Pacira Pharmaceuticals, Inc.
$ 212424 The total value of shares held by Robert J. Weiland
Insider Rank

Robert J. Weiland ranks 29,720 out of 350,000 insiders. Go to Insider Ranking to see more.

Address: C/O PACIRA PHARMACEUTICALS, INC. 5 SYLVAN WAY, SUITE 300 PARSIPPANY 07054 NJ

Companies in which Robert J. Weiland is an Insider

CymaBay Therapeutics, Inc.

Trading Symbol: CBAY
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Weiland: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 31 2019
$CBAY Market Capitalization: $52.52M
$CBAY Previous Close: $2.05

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Pacira Pharmaceuticals, Inc.

Trading Symbol: PCRX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Robert J. Weiland: Chief Commercial Officer
Holdings: 5,088 shares
Current Value: $212,424
Latest Transaction: Jun 06 2018
$PCRX Market Capitalization: $1.57B
$PCRX Previous Close: $41.75

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 1x
Shares Bought: 4,500
Shares Sold: 373
Share Difference: +4,127
Value Difference: +$12,316

Latest Insider Trading Transactions of Robert J. Weiland

Sentiment: All, CBAY, PCRX

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 31 2019CBAYCymaBay Therapeuti ...Weiland Robert J.DirectorOption ExerciseA8.4327,705233,55327,705
Jun 06 2018PCRXPacira Pharmaceuti ...Weiland Robert J.Chief Commercial Of ...SellS33.0237312,3165,0885.5 K to 5.1 K (-6.83 %)
Jan 26 2018CBAYCymaBay Therapeuti ...Weiland Robert J.DirectorOption ExerciseA11.6916,000187,04016,000
Sep 26 2017CBAYCymaBay Therapeuti ...Weiland Robert J.DirectorOption ExerciseA7.477,50056,0257,500
Jun 30 2017CBAYCymaBay Therapeuti ...Weiland Robert J.DirectorOption ExerciseA5.5015,00082,50015,000
Jun 16 2017PCRXPacira Pharmaceuti ...Weiland Robert J.Chief Commercial Of ...Option ExerciseA44.209,000397,8009,000
Jun 16 2017PCRXPacira Pharmaceuti ...Weiland Robert J.Chief Commercial Of ...GrantA0.004,50004,864364 to 4.9 K (+1,236.26 %)

View all Robert J. Weiland insider transactions.